Earlier today, Anthem Blue Cross and Blue Shield’s parent company announced that it has entered into a definitive agreement with Cigna Corporation, under which the parent company will acquire Cigna in a cash and stock transaction. The deal is targeted to close in the second half of 2016. Cigna stockholders still need to approve the agreement, and Anthem shareholders need to approve the issuance of shares in the transaction.
The parties face significant hurdles for FTC approval. Among the key provisions in the U.S. antitrust law is one designed to prevent anti-competitive mergers or acquisitions.
Click here for additional information